{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041636","form_type":"8-K/A","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2026-09-05T01:55:25+00:00","discovered_at":"2026-09-08T10:05:00.390624+00:00","generated_at":"2026-09-08T10:05:11.222141+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Indaptus enters $100M ATM equity offering agreement with H.C. Wainwright","bullets":["Amended and restated ATM agreement executed Aug 28, 2026, replacing June 1, 2022 pact with H.C. Wainwright.","Company may sell up to $100M in common stock through Wainwright as sales agent or principal.","Placement fee of 3.0% of gross sales proceeds for agent sales; no obligation to sell any shares.","Prospectus supplement filed Aug 31, 2026, amended Sept 4, 2026 to update dilution disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041636","json":"https://secwatch.observer/filing/0001493152-26-041636.json","markdown":"https://secwatch.observer/filing/0001493152-26-041636.md","text":"https://secwatch.observer/filing/0001493152-26-041636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226041636/0001493152-26-041636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226041636/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-08T10:05:11.222141+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}